Advertisement

Topics

Taro Provides Results for Year Ended March 31, 2018

17:57 EDT 17 May 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2018. Quarter ended March 31, 2018 Highlights ─ com...

Other Sources for this Article

Taro Pharmaceutical Industries Ltd.
Mariano Balaguer, 914-345-9001
VP, Chief Financial Officer
Mariano.Balaguer@Taro.com
or
William J. Coote, 914-345-9001
AVP, Business Finance, Treasurer and Investor Relations
William.Coote@Taro.com

NEXT ARTICLE

More From BioPortfolio on "Taro Provides Results for Year Ended March 31, 2018"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...